These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
313 related items for PubMed ID: 11838629
1. A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder. Liebowitz MR, Stein MB, Tancer M, Carpenter D, Oakes R, Pitts CD. J Clin Psychiatry; 2002 Jan; 63(1):66-74. PubMed ID: 11838629 [Abstract] [Full Text] [Related]
7. A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. Wagner KD, Berard R, Stein MB, Wetherhold E, Carpenter DJ, Perera P, Gee M, Davy K, Machin A. Arch Gen Psychiatry; 2004 Nov; 61(11):1153-62. PubMed ID: 15520363 [Abstract] [Full Text] [Related]
9. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD. J Clin Psychiatry; 2001 Nov; 62(11):860-8. PubMed ID: 11775045 [Abstract] [Full Text] [Related]
10. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial. Stein MB, Liebowitz MR, Lydiard RB, Pitts CD, Bushnell W, Gergel I. JAMA; 1998 Aug 26; 280(8):708-13. PubMed ID: 9728642 [Abstract] [Full Text] [Related]
11. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB. J Clin Psychiatry; 2006 Feb 26; 67(2):288-96. PubMed ID: 16566626 [Abstract] [Full Text] [Related]
12. Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline. Ball SG, Kuhn A, Wall D, Shekhar A, Goddard AW. J Clin Psychiatry; 2005 Jan 26; 66(1):94-9. PubMed ID: 15669894 [Abstract] [Full Text] [Related]
13. The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder. Stein DJ, Stein MB, Goodwin W, Kumar R, Hunter B. Psychopharmacology (Berl); 2001 Nov 26; 158(3):267-72. PubMed ID: 11713616 [Abstract] [Full Text] [Related]
14. Efficacy of sertraline in a 12-week trial for generalized anxiety disorder. Allgulander C, Dahl AA, Austin C, Morris PL, Sogaard JA, Fayyad R, Kutcher SP, Clary CM. Am J Psychiatry; 2004 Sep 26; 161(9):1642-9. PubMed ID: 15337655 [Abstract] [Full Text] [Related]
15. A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder. Liebowitz MR, Mangano RM, Bradwejn J, Asnis G, SAD Study Group. J Clin Psychiatry; 2005 Feb 26; 66(2):238-47. PubMed ID: 15705011 [Abstract] [Full Text] [Related]
16. Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. Montgomery SA, Tobias K, Zornberg GL, Kasper S, Pande AC. J Clin Psychiatry; 2006 May 26; 67(5):771-82. PubMed ID: 16841627 [Abstract] [Full Text] [Related]